Bausch Health Companies | VRX - Debt


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Bausch Health Companies

Bausch Health Companies Inc reported $20.65B in Debt for its fiscal quarter ending in March of 2023.


Debt Change
Amgen AMGN:US USD 61.6B 22.65B
ANI Pharmaceuticals ANIP:US USD 286.31M 212K
Bausch Health Companies Inc VRX:CN USD 20.65B 113M
Biogen BIIB:US USD 6.28B 1.7M
Bristol-Myers Squibb BMY:US USD 37.83B 1.49B
Catalent CTLT:US USD 4.85B 649M
Danaher DHR:US USD 19.83B 155M
Drreddys Laboratories RDY:US INR 13.47B 4.19B
Eli Lilly LLY:US USD 18.88B 2.64B
Endo International ENDP:US USD 7.69B 7.69B
Horizon Pharma HZNP:US USD 2.56B 2.61M
Pacira PCRX:US USD 553.77M 135.7M
Perrigo PRGO:US USD 4.1B 5M
Phibro Animal Health PAHC:US USD 481.44M 5.21M
Prestige Brands PBH:US USD 1.35B 79M
Revance Therapeutics RVNC:US USD 398.47M 18.43M
Supernus Pharmaceuticals SUPN:US USD 480.86M 78.9M
Vertex Pharmaceuticals VRTX:US USD 417.6M 13.2M
Zoetis ZTS:US USD 6.56B 1.34B